■ Digital health company Verana has launched the Qdata Glaucoma module, which it says is the “first-and-only data module reflective of a full, real-world glaucoma patient journey to accelerate quality insights.”

The data comprises more than 5 million deidentified patients, ranging from suspect diagnosis through treatment and outcomes obtained from the real-world American Academy of Ophthalmology IRIS Registry. The module provides a comprehensive look into patients’ experience of glaucoma that can provide useful insights for researchers and physicians.

“One of the unique aspects about Qdata Glaucoma is that the treatment and outcomes data are specific to a given eye,” said Robert Chang, MD, associate professor of ophthalmology at Stanford University, in a news release. “Verana Health has a unique team of clinicians, data scientists, and research design experts all working together to ensure accuracy as well as acknowledge some limitations in real-world big data.” GP